Drug Topics

AUGUST 19, 2024

The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.

220

220

Pharmacy Times

AUGUST 19, 2024

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

145

145

STAT

AUGUST 19, 2024

Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.

Nursing Homes 145

Nursing Homes Hospitals 145

Pharmacy Times

AUGUST 19, 2024

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

139

139

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

AUGUST 19, 2024

The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can blanket an entire household, burdening spouses and other family members with stress and anxiety and the exhausting routine of treating a life-threatening disease. But while standards exist for assessing and managing distress in patients, it’s often “hidden” in family members, sometimes with devastating

145

145

Drug Topics

AUGUST 19, 2024

A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.

Community Pharmacies 112

Community Pharmacies 112

pharmaphorum

AUGUST 19, 2024

Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network

133

133

STAT

AUGUST 19, 2024

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.

Insurance 145

Insurance Hospitals 145

Pharmacy Times

AUGUST 19, 2024

The OTC antibody test can detect current or past infection but should be followed by additional testing to confirm diagnosis.

FDA 132

FDA 132

STAT

AUGUST 19, 2024

For the second time in three years, the WHO has declared an mpox outbreak a public health emergency of international concern. Since news of the epidemic, the media has circulated images of patients infected with mpox. Some of these photographs show mpox on patients’ arms, legs, and hands, but others are headshots that resemble mugshots of African people with mpox covering their faces.

139

139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

AUGUST 19, 2024

Noticing indicators of IVIG non-responsiveness can lead to better outcomes among patients with Kawasaki disease as treatment is adjusted.

123

123

STAT

AUGUST 19, 2024

As the Federal Trade Commission scrutinizes the pharmaceutical industry, there is growing debate about whether the regulator may next target a deal that some experts say could make it easier for Novo Nordisk to boost production of a key drug — at the expense of competitors. At issue is a complicated transaction sparked by sporadic shortages of one of the world’s hottest-selling medications — the weight loss treatment Wegovy.

117

117

Drug Topics

AUGUST 19, 2024

Both the restructuring of direct and indirect remuneration fees and health care cyber attacks made an impact on the industry in the first half of 2024.

98

98

STAT

AUGUST 19, 2024

A group representing molecular pathologists sued the Food and Drug Administration on Monday over its plan to regulate lab-developed tests.  It’s the second legal challenge to the rule, following the American Clinical Laboratory Association’s suit in May. The suit, filed in Texas by the Association for Molecular Pathology and University of Texas pathologist Michael Laposata, claims that the FDA overstepped its regulatory bounds when deciding to regulate lab-developed tests.

FDA 114

FDA 114

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

AUGUST 19, 2024

Focus group participants were receptive to using eHealth tools, but noted several barriers such as cost and availability.

112

112

Pharmacy Times

AUGUST 19, 2024

Fam-trastuzumab deruxtecan-nxki has received 4 breakthrough therapy designations, including the latest approval.

FDA 123

FDA 123

Fierce Pharma

AUGUST 19, 2024

Genmab is revamping its executive team as the Danish antibody specialist expands its commercialization efforts and looks to evolve into “a fully integrated biotech innovation powerhouse.” | Genmab is revamping its executive team as the Danish antibody specialist expands its commercialization efforts and looks to evolve into “a fully integrated biotech innovation powerhouse.

102

102

STAT

AUGUST 19, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. A self-interested plea from Peter Orszag Peter Orszag, CEO of Lazard, went on CNBC last week and criticized how the Federal Trade Commission and Department of Justice were gumming up health care mergers.

Hospitals 104

Hospitals 104

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

AUGUST 19, 2024

Liquidia and its dry powder Yutrepia is back in FDA limbo after the agency opted for a tentative approval as opposed to a standard nod. | The agency granted a broad regulatory exclusivity to rival United Therapeutics and its Tyvasvo DPI, leaving Liquidia's Yutrepia, which uses the same active drug, in FDA limbo until 2025.

FDA 102

FDA 102

Pharmacy Times

AUGUST 19, 2024

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

169

169

Fierce Pharma

AUGUST 19, 2024

Industry watchers largely breathed a sigh of relief last week after the Medicare price cuts for certain costly drugs under the Inflation Reduction Act initially appeared better than expected. | The magnitude of price cuts under the Inflation Reduction Act initially appeared better than expected. However, that rosy view may have missed an important point, one analyst team contends.

100

100

Fierce Healthcare

AUGUST 19, 2024

Humana has agreed to pay $90 million to settle a False Claims Act case related to its Medicare Part D contracts, according to the attorneys representing the whistleblower in the case. | Humana has agreed to pay $90 million to settle a False Claims Act case related to its Medicare Part D contracts, according to the attorneys representing the whistleblower in the case.

115

115

Fierce Pharma

AUGUST 19, 2024

With its rapid development of the Jynneos vaccine, Bavarian | After the WHO declared mpox a global health emergency for the second time in 25 months, Bavarian Nordic said it could ramp up manufacturing to supply 12 million doses of its Jynneos vaccine through 2025 to contain the virus in Africa.

Vaccines 99

Vaccines 99

OctariusRx

AUGUST 19, 2024

The 2024 version of the OctariusRx medication safety quiz is about to be released. Ongoing education and assessments of staff medication management competency are standards of good practice. Medication competency and your consultant pharmacist are two things that should go hand-in-hand. How are you assessing your staff? Use our tool to help enhance patient safety and satisfy regulatory requirements.

Controlled Substances 95

Controlled Substances Labelling 95

The Checkup by Singlecare

AUGUST 19, 2024

Jardiance (empagliflozin) is a brand-name prescription that helps adults with Type 2 diabetes manage their blood sugar levels. It can also lower the risk of death from heart disease and hospitalization for heart failure in adults whose hearts cannot pump enough blood to the rest of their body. Additionally, Jardiance can reduce the risk of worsening kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalization in adults with chronic kidney disease.

Insurance 92

Insurance Hospitals Dosage 92

Drug Topics

AUGUST 19, 2024

Participants were asked to rate their level of concern on 26 health topics.

112

112

Pharmaceutical Technology

AUGUST 19, 2024

Eli Lilly has concluded the acquisition of Morphic Holding at $57 per share, bolstering its inflammatory bowel disease portfolio.

105

105

pharmaphorum

AUGUST 19, 2024

Safeguarding patient data is crucial in the healthcare industry. This article outlines four steps to consider when assessing your IT infrastructure to protect against ransomware and ensure the security of patient data.

73

73

Pharmaceutical Technology

AUGUST 19, 2024

Cyril Ramaphosa, the president of South Africa, has asked the WHO to ensure African countries have equitable access to mpox vaccines.

Vaccines 98

Vaccines 98

Pharmacy Times

AUGUST 19, 2024

Glucagon-like peptide-1 receptor agonists and sodium-glucose contransporter-2 inhibitors have been added as first-line therapy recommendation for type 2 diabetes, the first since metformin

65

65

Pharmaceutical Technology

AUGUST 19, 2024

Looking to potentially market their flagship drug SPI-1005, Sound CEO Jonathan Kil is keen to retain WuXi AppTec as a partner.

98

98

Fierce Healthcare

AUGUST 19, 2024

Virtual chronic care management company Omada is partnering with the state of Alaska to prevent and manage diabetes and hypertension. | Alaska is the biggest U.S. state, and much of it is rural. Many rural Alaskan towns lack in-person diabetes management support programs. The state department of health is subsidizing the cost of Omada's virtual diabetes and hypertension programs to fill the gap.

66

66

pharmaphorum

AUGUST 19, 2024

Pfizer and BioNTech have a phase 3 mishap with their combined COVID-19 and influenza vaccine, handing Moderna an advantage

Vaccines 87

Vaccines 87